Bezjak, AndreaMSc, MDCM, FRCPC
Dr. Andrea Bezjak
Princess Margaret Hospital
610 University Avenue
Toronto, ON M5G 2M9
Tel. (416) 946-2132
Fax (416) 946-6561
Admin Assistant
Patricia Lee
Academic Rank
Professor
Professional Qualifications
BMed Sc, Kuwait University
MSc, Clinical Epidemiology, McMaster University
MDCM, McGill University
FRCPC, Radiation Oncology, Internal Medicine
Appointments
Professor, Department of Radiation Oncology, University of Toronto
Associate Core Faculty, Clinical Epidemiology & Health Care Research Program, University of Toronto
Associate Professor, Department of Health Administration, University of Toronto
Radiation Oncologist, Princess Margaret Hospital/University Health Network
Addie MacNaughton Chair in Thoracic Radiation Oncology
Associate Member (limited term), Graduate Department of Community Health, University of Toronto
Associate Member (limited term), Graduate Department of Health Administration, University of Toronto
Academic & Clinical Interests
- Lung cancer
- High precision radiotherapy
- Thymomas
- Palliative radiotherapy
- Quality of life
- Symptom management and assessment
- Clinical trials methodology
Current Research Projects
- Assessing respiratory movement of lung cancer using 4D CT
- Phase I/II study of stereotactic RT for small lung lesions
- Concurrent medications as modifiers of RT pneumonitis
- Comparison of different methods of assessing palliative response after RT for painful bone metastases
Selected Publications
See current publications list at PubMed.
Bitar R, Bezjak A, Mah K, Loblaw DA, Gotowiec AP, Devins GM: Does Tumor Status Influence Cancer Patients’ Satisfaction with the Doctor-Patient Interaction? Supportive Care in Cancer 12(1):34-40, 2004.
Ringash J, Bezjak A, O’Sullivan B, Redelmeier DA: Interpreting Differences in Quality of Life: The Fact- H&N in Laryngeal Cancer Patients. Qual Life Res 13:725-733, 2004.
Bezjak A, Tu D, Bacon M,Osoba D, Zee B, Stuart G, Piccart M, Eisenhauer E: Quality of life in ovarian cancer patients: Comparison of placlitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. J Clin Oncol 22(22):4595 – 4603, 2004.
Osoba D, Bezjak A, Brundage M, Zee B, Tu D, Pater J: Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. Eur J Can 41:280-287, 2005.